Unexpected malignancy rate of 1630 hysterectomies performed for benign indications: A 10-year retrospective analysis

ArticleAçık Erişim

Özet

OBJECTIVE Hysterectomy is one of the most common operations in gynecology. This study aimed to investigate the incidence of occult gynecologic malignancies in women undergoing hysterectomy for benign indications. METHODS In this retrospective study, the medical records of patients who underwent hysterectomy for benign indications between 2009-2019 were evaluated using the hospital’s electronic system. RESULTS During the study period, 1630 cases underwent hysterectomy for benign indications. The mean age of the patients was 48.4±6.9 years. The most common indications for hysterectomy were leiomyoma (n=788, 48.3%) and abnormal uterine bleeding (n=539, 33.1%). In the final histopathological evaluation results, malignancy was identified in 12 cases (0.73%), and the mean age of these cases was 50.41±12 years. These malignancies included four leiomyosarcomas (33.33%), one endometrial sarcoma (8.33%), two endo-metrial adenocarcinomas (16.66%), four ovarian carcinomas (33.33%), and one ovarian fibrosarcoma (8.33%). Preoperative endometrial sampling was performed in 1160 cases (71.16%). All of the occult malignant cases had preoperative endometrial sampling and no malignancy was observed in the endometrial pathology results. CONCLUSION Unexpected malignancy rate in women who underwent hysterectomies for benign indications was 0.73%, and 58.3% of them were related to the uterus, and 41.6% were related to ovarian tissues. Occult uterine and ovarian malignancies may be observed in hysterectomies performed for benign indications. Detailed preoperative evaluation is essential to avoid the increased risk of mortality and morbidity caused by late diagnosis of malignancy. © 2021, Turkish Society for Radiation Oncology.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13249Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5505/tjo.2020.2561Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKadioğlu, Berrin Göktuğ
dc.contributor.authorAksoy, Ayşe Nur
dc.contributor.authorAkalp Özmen, Sevilay
dc.contributor.authorUluğ, Paşa
dc.contributor.authorAydin, Özkan
dc.date.accessioned2026-10-18T20:28:05.439751753Z
dc.date.available2026-10-18T20:28:05.439751753Z
dc.date.issued2021
dc.description.abstractOBJECTIVE Hysterectomy is one of the most common operations in gynecology. This study aimed to investigate the incidence of occult gynecologic malignancies in women undergoing hysterectomy for benign indications. METHODS In this retrospective study, the medical records of patients who underwent hysterectomy for benign indications between 2009-2019 were evaluated using the hospital’s electronic system. RESULTS During the study period, 1630 cases underwent hysterectomy for benign indications. The mean age of the patients was 48.4±6.9 years. The most common indications for hysterectomy were leiomyoma (n=788, 48.3%) and abnormal uterine bleeding (n=539, 33.1%). In the final histopathological evaluation results, malignancy was identified in 12 cases (0.73%), and the mean age of these cases was 50.41±12 years. These malignancies included four leiomyosarcomas (33.33%), one endometrial sarcoma (8.33%), two endo-metrial adenocarcinomas (16.66%), four ovarian carcinomas (33.33%), and one ovarian fibrosarcoma (8.33%). Preoperative endometrial sampling was performed in 1160 cases (71.16%). All of the occult malignant cases had preoperative endometrial sampling and no malignancy was observed in the endometrial pathology results. CONCLUSION Unexpected malignancy rate in women who underwent hysterectomies for benign indications was 0.73%, and 58.3% of them were related to the uterus, and 41.6% were related to ovarian tissues. Occult uterine and ovarian malignancies may be observed in hysterectomies performed for benign indications. Detailed preoperative evaluation is essential to avoid the increased risk of mortality and morbidity caused by late diagnosis of malignancy. © 2021, Turkish Society for Radiation Oncology.
dc.identifier.doi10.5505/tjo.2020.2561
dc.identifier.endpage176
dc.identifier.issn1300-7467
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85108640951
dc.identifier.startpage171
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13249
dc.identifier.volume36
dc.identifier.wosWOS:000658350800005
dc.language.isoen
dc.publisherIstanbul Tip Fakultesi
dc.relation.ispartofTurk Onkoloji Dergisi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBenign
dc.subjectHysterectomy
dc.subjectIndication
dc.subjectMalignancy
dc.subjectPathology
dc.subjectabdominal hysterectomy
dc.subjectadenocarcinoma
dc.subjectadult
dc.subjectArticle
dc.subjectbenign neoplasm
dc.subjectcancer cell
dc.subjectcancer surgery
dc.subjectechography
dc.subjectelectrocardiography
dc.subjectendometrial disease
dc.subjectendometriosis
dc.subjectendometrium cancer
dc.subjectendometrium hyperplasia
dc.subjectendometrium sarcoma
dc.subjectfemale
dc.subjectfrozen section
dc.subjecthistopathology
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectimmunohistochemistry
dc.subjectintensive care unit
dc.subjectlaparoscopy
dc.subjectlaparotomy
dc.subjectleiomyoma
dc.subjectleiomyosarcoma
dc.titleUnexpected malignancy rate of 1630 hysterectomies performed for benign indications: A 10-year retrospective analysis
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.trdizin0
rdl.citation.wos0
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
rdl.departmentATATÜRK ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)